Title: From farm to pharma

Biography:

For almost a decade Roei Zerahia has been serving in senior management positions in CANNDOC (one of the first Israeli license producer). During this period, he acquired extensive knowledge and experience in the various fields of operation in the cannabis industry. During 2018, as the company’s CEO, Roei led the company to an acquisition by Intercure (INCR.TA) a pharmaceutical public company, and which became the first pharma grade cannabis company in Israel. During his tenure as the company’s CEO, the company reached a valuation of 1.2 billion NIS.

With a global understanding of the evolving cannabis arena, and as a faculty member and a senior lecturer in the Israeli academy since 2005, Roei lectures on different aspects of the cannabis industry around the globe. Roei was invited to speak in the World Economic Forum (WEF) in Davos, Switzerland regarding the future of the medical cannabis industry, and gave a TED talk regarding his journey in the cannabis space.

Abstract

The presentation will give an overview of the cannabis industry in the last couple of years (including during COVID-19), and the big change in people’s minds from an agricultural crop to a prescribed medicine. We will talk about the big bang that happened all around the world, and how different continents are progressing and how they define the cannabis space. We will show the forecast of this industry for the next couple of years in north America, Europe and other territories including Israel which made big changes in its regulation towards medical grade cannabis which is being sold in pharmacies only by a doctor’s prescription according to specific cannabinoids profiles.